vimarsana.com
Home
Live Updates
Linvoseltamab Elicits Deep Responses in Late-Stage R/R Multiple Myeloma : vimarsana.com
Linvoseltamab Elicits Deep Responses in Late-Stage R/R Multiple Myeloma
Linvoseltamab elicited responses with acceptable safety in patients with relapsed/refractory multiple myeloma, including difficult-to-treat subsets
Related Keywords
United States ,
New York ,
Americans ,
Sundar Jagannath ,
Tisch Cancer Institute ,
Clinical Myeloma Program At Perlmutter Cancer Center ,
International Staging System ,
Multiple Myeloma ,
Mount Sinai ,
African Americans ,
Blood Cancers ,
Clinical Myeloma Program ,
Perlmutter Cancer Center ,
Linvoseltamab ,
Myeloma ,
Linker Mm1 Study ,
Bispecific Antibody ,
Bbs ,
Taacr ,
Aacr Annual Meeting ,
vimarsana.com © 2020. All Rights Reserved.